Tenders of Aok Plus The Health Fund For Saxony And

Tenders of Aok Plus The Health Fund For Saxony And

AOK PLUS The Health Fund For Saxony And Tender

Healthcare and Medicine
Germany
For the tender 'conclusion of non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open-house model for the active ingredient tolvaptan (ATC code: G04BX21)'
Closing Date31 Aug 2026
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Others
Germany
For tendering 'absolute non-exc. Am-rabattv. According to § 130a para. 8 Sgb W In the way of a Sog. Oh-modells To Ws Mesalazin In The Dar. Retardtabl. (atc-code After Who: A07ec02)'
Closing Date30 Apr 2025
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Corrigendum : Closing Date Modified
Germany
To tender for the conclusion of non-exclusive medicament discounts according to § 130a para. 8 Sgb W In the Way of A Sog. Open-house Model To the active ingredient Fondaparinux (atc-code After Who: B01ax05')
Closing Date31 May 2025
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Others
Corrigendum : Closing Date Modified
Germany
To the tender 'delivery of letters up to 1,000g'
Closing Date13 Dec 2024
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Germany
To tender for the conclusion of non-exclusive medicament discounts according to § 130a para. 8 Sgb W In the way of a so-called open-house model To the active ingredient Piribedil (atc-code After Who: N04bc08)'
Closing Date28 Feb 2025
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Healthcare and Medicine
Germany
To the tender 'Conclusion of non-exclusive drug discount agreements according to Section 130a Paragraph 8 SGB V by way of a so-called open-house model for the active ingredient beclometasone/formoterol (atc code according to Who: R03ak08)'
Closing Soon30 Nov 2024
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Healthcare and Medicine
Germany
For the tender 'conclusion of non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open-house model for the active ingredient tolvaptan (ATC code: C03xa01)'
Closing Date31 Aug 2026
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Healthcare and Medicine
Germany
To the tender 'Conclusion of non-exclusive drug discount agreements according to § 130a Para. 8 Sgb V by means of a so-called open-house model for the active substance alitretinoin (ATC code according to Who: D11ah04)'
Closing Date31 Aug 2025
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Healthcare and Medicine
Germany
To the tender 'Conclusion of non-exclusive drug discount agreements according to Section 130a Paragraph 8 SGB V by way of a so-called Oh model for the Ws Golimumab (atc code according to Who: L04ab06)'
Closing Date31 Dec 2024
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Others
Germany
In order to tender 'Finish non-exclusive Am-rabatt Agreements According to § 130a para. 8 Sgb W By A Sog. Oh-modells To the active ingredient Mebeverin (atc-code After Who: A03aa04')
Closing Date30 Apr 2025
Tender AmountRefer Documents 
31-40 of 40 active Tenders